Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Getting organized can be overwhelming, especially if you are also managing a health condition. Get tips for making progress a…
Three members of CSL Behring’s Intercontinental Commercial Operations team recently hit the pavement in London together.
CSL Behring is heading to the European Respiratory Society International Congress with a Walk for Alpha 1 and a symposium on …
The 2022 CSL Behring Broadmeadows Community Grant goes to the “Working Together” program that assists recent arrivals to Vic…
Uplifting Athletes is calling on researchers to apply for rare disease research funding for a chance to be drafted with NFL- …
CSL, a global biotech company, is working with aid organizations to provide life-saving medicines to impacted civilians. The …
The Immune Deficiency Foundation recently offered advice to patients who have immune deficiencies.
To stay well, experts recommend both a flu shot and a new, revamped vaccine against COVID-19.
CSL is taking action by setting 2030 carbon targets, CSL’s Chief Financial Officer says.
Americas
Asia Pacific
Middle East
Europe
